Nkgen BiotechNKGN
13F holders, Q4 2024 (December 31)25holders +6
8new positions
3sold out
$0.61avg. 13F price*
At the end of Q4 2024, 25 institutions reported holding Nkgen Biotech Inc. (NKGN) in their 13F filings, up 6 from Q3 2024. 8 opened new positions and 3 sold out. The largest holders were Pathstone Holdings, LLC ($1.8M), Meteora Capital, LLC ($1.8M) and University of Chicago ($360K).
- Company
- Nkgen Biotech Inc.
- CUSIP
- 65488A101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $2.2M |
| Exits | 3 | $43K |
All 13F filers, Q3 2024 → Q4 2024: 5,421,292 shares bought and 822,448 shares sold, net +4,598,844 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 25 holders
| Pathstone Holdings, LLC | 0.01% | New | 2,797,661 | $1.8M |
| Meteora Capital, LLC | 0.67% | Add +213.3% | 2,772,145 | $1.8M |
| University of Chicago | 0.34% | No change | 550,000 | $360K |
| Diametric Capital, LP | 0.23% | No change | 518,134 | $339K |
| Kepos Capital LP | 0.13% | New | 230,022 | $151K |
| Vanguard Group Inc. | 0.00% | No change | 227,804 | $149K |
| Sequoia Financial Advisors, LLC | 0.00% | Add +126.1% | 156,000 | $102K |
| Magnetar Financial LLC | 0.00% | New | 267,508 | $96K |
| Geode Capital Management, LLC | 0.00% | Add +12.8% | 127,168 | $83K |
| Advisory Research Inc. | 0.00% | New | 43,088 | $28K |
| XTX Topco Ltd | 0.00% | New | 33,625 | $22K |
| Northern Trust Corp. | 0.00% | No change | 29,082 | $19K |
| Periscope Capital Inc. | 0.01% | New | 25,000 | $16K |
| Two Sigma Securities, LLC | 0.00% | Reduce -8.1% | 22,495 | $15K |
| Two Sigma Investments, LP | 0.00% | New | 22,356 | $15K |
| SkyOak Wealth, LLC | 0.00% | New | 13,164 | $9K |
| State Street Corp. | 0.00% | No change | 11,200 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -76.3% | 2,782 | $2K |
| BlackRock, Inc. | 0.00% | No change | 1,854 | $1K |
| SBI Securities Co., Ltd. | 0.00% | — | 902 | $591 |
| UBS Group AG | 0.00% | Reduce -94.8% | 763 | $500 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 500 | $328 |
| Bank of America Corp. | 0.00% | Reduce -3.8% | 102 | $67 |
| JPMorgan Chase & Co. | 0.00% | Add +45.2% | 45 | $29 |
| Polar Asset Management Partners Inc. | 0.00% | Reduce -57.7% | 500,000 | $0 |
"% of holder's portfolio" is NKGN's weight in each manager's 13F, not the share of Nkgen Biotech Inc. the manager owns.